• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors.直肠神经内分泌肿瘤患者的特征及长期预后
World J Gastroenterol. 2014 Nov 21;20(43):16252-7. doi: 10.3748/wjg.v20.i43.16252.
2
[Prognostic factor analysis of surgical treatment in patients with rectal neuroendocrine neoplasms].[直肠神经内分泌肿瘤患者手术治疗的预后因素分析]
Zhonghua Yi Xue Za Zhi. 2014 Apr 29;94(16):1237-40.
3
Hindgut neuroendocrine neoplasms - characteristics and prognosis.后肠神经内分泌肿瘤——特征与预后
Arch Med Sci. 2017 Oct;13(6):1427-1432. doi: 10.5114/aoms.2017.64979. Epub 2017 Jan 6.
4
Analysis of the factors affecting lymph node metastasis and the prognosis of rectal neuroendocrine tumors.影响直肠神经内分泌肿瘤淋巴结转移及预后的因素分析
Int J Clin Exp Pathol. 2015 Oct 1;8(10):13331-8. eCollection 2015.
5
[Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].胃肠胰神经内分泌肿瘤患者的临床病理特征及预后因素的多因素分析
Zhonghua Yi Xue Za Zhi. 2013 May 14;93(18):1411-4.
6
[Risk factors associated with lymph node metastasis and prognosis in 69 patients with rectal neuroendocrine tumors].[69例直肠神经内分泌肿瘤患者淋巴结转移及预后的相关危险因素]
Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Jun;17(6):578-81.
7
lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.在接受全直肠系膜切除术后进行放化疗的Ⅲ期直肠癌患者中,淋巴结比率作为一种预后因素。
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):796-802. doi: 10.1016/j.ijrobp.2008.08.065. Epub 2009 Mar 14.
8
Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.直肠神经内分泌肿瘤局部区域复发的预后因素。
Dis Colon Rectum. 2018 Feb;61(2):187-192. doi: 10.1097/DCR.0000000000000996.
9
Short- and Long-term Outcomes of Laparoscopic Total Mesenteric Excision for Neuroendocrine Tumors of the Rectum.腹腔镜全直肠系膜切除术治疗直肠神经内分泌肿瘤的短期和长期疗效
Dis Colon Rectum. 2017 Mar;60(3):284-289. doi: 10.1097/DCR.0000000000000745.
10
Clinical and prognostic features of rectal neuroendocrine tumors.直肠神经内分泌肿瘤的临床和预后特征。
Neuroendocrinology. 2013;98(3):180-7. doi: 10.1159/000355612. Epub 2013 Nov 5.

引用本文的文献

1
Risk factors for lateral pelvic lymph node metastasis in patients with rectal neuroendocrine tumors: a systematic review and meta-analysis.直肠神经内分泌肿瘤患者盆腔侧方淋巴结转移的危险因素:一项系统评价和Meta分析
Front Oncol. 2025 Jan 31;15:1500623. doi: 10.3389/fonc.2025.1500623. eCollection 2025.
2
A Rare Case of Poorly Differentiated Neuroendocrine Carcinoma of the Descending Colon with Regional Lymph Node Involvement Presenting in a Young Adult Nigerian Male: A Case Report.一名年轻成年尼日利亚男性降结肠低分化神经内分泌癌伴区域淋巴结转移的罕见病例:病例报告
Niger Med J. 2025 Jan 10;65(6):1160-1170. doi: 10.60787/nmj.v65i6.585. eCollection 2024 Nov-Dec.
3
Clinical outcomes after endoscopic resection and the risk of lymph node metastasis in rectal neuroendocrine tumors: a single-center retrospective study.直肠神经内分泌肿瘤内镜切除术后的临床结局和淋巴结转移风险:一项单中心回顾性研究。
Surg Endosc. 2024 Sep;38(9):5178-5186. doi: 10.1007/s00464-024-11088-z. Epub 2024 Jul 23.
4
Assessing the effectiveness and safety of surufatinib versus everolimus or sunitinib in advanced neuroendocrine neoplasms: insights from a real-world, retrospective cohort study using propensity score and inverse probability treatment weighting analysis.评估索凡替尼对比依维莫司或舒尼替尼治疗晚期神经内分泌肿瘤的有效性和安全性:一项使用倾向评分和逆概率处理加权分析的真实世界回顾性队列研究的见解
J Gastrointest Oncol. 2024 Apr 30;15(2):689-709. doi: 10.21037/jgo-24-218. Epub 2024 Apr 29.
5
Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study : Grade impact on workup of rectal NETs.直肠类癌瘤工作流程的分级影响:一项回顾性队列研究:分级对直肠神经内分泌肿瘤工作流程的影响。
World J Surg Oncol. 2024 Apr 16;22(1):98. doi: 10.1186/s12957-024-03379-5.
6
Correlation between clinicopathological characteristics and the clinical prognosis of patients with gastroenteropancreatic neuroendocrine tumors.胃肠胰神经内分泌肿瘤患者临床病理特征与临床预后的相关性
Mol Clin Oncol. 2023 Sep 13;19(5):85. doi: 10.3892/mco.2023.2681. eCollection 2023 Nov.
7
Case report: Indocyanine green fluorescence-guided imaging in laparoscope, a more sensitive detection technique of lateral lymph nodes metastases from rectal neuroendocrine tumors.病例报告:腹腔镜下吲哚菁绿荧光引导成像,一种检测直肠神经内分泌肿瘤侧方淋巴结转移更敏感的技术。
Front Oncol. 2022 Dec 16;12:1101990. doi: 10.3389/fonc.2022.1101990. eCollection 2022.
8
Nomogram for individually predicting overall survival in rectal neuroendocrine tumours.预测直肠神经内分泌肿瘤患者总生存的列线图。
BMC Cancer. 2020 Sep 9;20(1):865. doi: 10.1186/s12885-020-07328-9.
9
Clinical analysis of 547 patients with neuroendocrine tumors in a Chinese population: A single-center study.中国人群中 547 例神经内分泌肿瘤的临床分析:一项单中心研究。
Cancer Med. 2019 Jul;8(8):3729-3737. doi: 10.1002/cam4.2259. Epub 2019 May 24.
10
Long-term outcomes according to additional treatments after endoscopic resection for rectal small neuroendocrine tumors.直肠小类器官神经内分泌肿瘤内镜切除后追加治疗的长期结果。
Sci Rep. 2019 Mar 20;9(1):4911. doi: 10.1038/s41598-019-40668-6.

本文引用的文献

1
A tailored approach for endoscopic treatment of small rectal neuroendocrine tumor.一种针对直肠小神经内分泌肿瘤的内镜治疗的个性化方法。
Surg Endosc. 2014 Oct;28(10):2931-8. doi: 10.1007/s00464-014-3555-1. Epub 2014 May 23.
2
Endoscopically identified well-differentiated rectal carcinoid tumors: impact of tumor size on the natural history and outcomes.经内镜识别的高分化直肠类癌肿瘤:肿瘤大小对自然病程和预后的影响。
Gastrointest Endosc. 2014 Jul;80(1):144-51. doi: 10.1016/j.gie.2013.11.031. Epub 2014 Jan 23.
3
Endoscopic resection yields reliable outcomes for small rectal neuroendocrine tumors.内镜下切除可为小直肠神经内分泌肿瘤提供可靠的结果。
Dig Endosc. 2014 Jul;26(4):556-63. doi: 10.1111/den.12232. Epub 2014 Jan 22.
4
Long term outcomes of neuroendocrine carcinomas (high-grade neuroendocrine tumors) of the colon, rectum, and anal canal.结直肠肛门部神经内分泌癌(高级别神经内分泌肿瘤)的长期预后。
J Visc Surg. 2014 Feb;151(1):3-7. doi: 10.1016/j.jviscsurg.2013.12.007. Epub 2014 Jan 8.
5
Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: epidemiological changes in Germany.临床上检测到的胃肠胰神经内分泌肿瘤正在增加:德国的流行病学变化。
World J Gastroenterol. 2013 Dec 21;19(47):9012-9. doi: 10.3748/wjg.v19.i47.9012.
6
Surveillance strategy for rectal neuroendocrine tumors according to recurrence risk stratification.根据复发风险分层的直肠神经内分泌肿瘤监测策略。
Dig Dis Sci. 2014 Apr;59(4):850-6. doi: 10.1007/s10620-013-2972-7. Epub 2013 Dec 10.
7
Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature.胃肠胰神经内分泌肿瘤的发病率:文献系统综述。
Endocr Relat Cancer. 2014 May 6;21(3):R153-63. doi: 10.1530/ERC-13-0125. Print 2014 Jun.
8
Clinical outcomes of rectal neuroendocrine tumors ≤ 10 mm following endoscopic resection.直肠神经内分泌肿瘤≤10mm 内镜切除后的临床结果。
Endoscopy. 2013 Dec;45(12):1018-23. doi: 10.1055/s-0033-1344860. Epub 2013 Nov 28.
9
Clinical and prognostic features of rectal neuroendocrine tumors.直肠神经内分泌肿瘤的临床和预后特征。
Neuroendocrinology. 2013;98(3):180-7. doi: 10.1159/000355612. Epub 2013 Nov 5.
10
Endoscopic mucosal resection for rectal carcinoids under micro-probe ultrasound guidance.在微探头超声引导下经内镜黏膜切除术治疗直肠类癌。
World J Gastroenterol. 2013 Apr 28;19(16):2555-9. doi: 10.3748/wjg.v19.i16.2555.

直肠神经内分泌肿瘤患者的特征及长期预后

Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors.

作者信息

Chi Yihebali, Du Feng, Zhao Hong, Wang Jin-Wan, Cai Jian-Qiang

机构信息

Yihebali Chi, Feng Du, Hong Zhao, Jin-Wan Wang, Jian-Qiang Cai, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China.

出版信息

World J Gastroenterol. 2014 Nov 21;20(43):16252-7. doi: 10.3748/wjg.v20.i43.16252.

DOI:10.3748/wjg.v20.i43.16252
PMID:25473180
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4239514/
Abstract

AIM

To analyze the clinicopathologic characteristics and prognostic factors of rectal neuroendocrine tumors.

METHODS

The records of 48 patients with rectal neuroendocrine tumors who were treated at the Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, from March 2004 to September 2009 were retrospectively reviewed. The clinicopathological data were extracted and analyzed, and patients were followed-up by telephone or follow-up letter to determine their survival status. Follow-up data were available for all 48 patients. Uni- and multivariate Cox regression analyses were performed to determine the prognostic factors significantly associated with overall survival.

RESULTS

The tumors occurred mostly in the middle and lower rectum, and the most prominent symptoms experienced by patients were hematochezia and diarrhea. The median distance between the tumors and the anal edges was 5.0 ± 2.257 cm, and the median diameter of the tumors was 0.8 ± 1.413 cm. The major pathological type was a typical carcinoid tumor, which accounted for 93.8% (45/48) of patients. Tumor-node-metastasis (TNM) stages I, II, III and IV tumors accounted for 78.8%, 3.9%, 9.6% and 7.7% of patients, respectively. The main treatment method, in 72.9% (35/48) of patients, was transanal extended excision. The 1-, 3- and 5-year survival rates of the whole group of patients were 100%, 93.7%, and 91.3%, respectively. Univariate analysis showed that age (P = 0.032), tumor diameter (P < 0.001), histological type (P < 0.001), TNM stage (P < 0.001), and surgical approach (P = 0.002) were all prognostic factors. On multivariate analysis, only the pathological type was shown to be an independent prognostic factor (HR = 2.797, 95%CI: 1.676-4.668, P = 0.004).

CONCLUSION

In patients with rectal neuroendocrine tumors, TNM stage I is the most common stage found, and lymph node or distant metastases are rarely seen. The pathological type of the tumor is an independent prognostic factor.

摘要

目的

分析直肠神经内分泌肿瘤的临床病理特征及预后因素。

方法

回顾性分析2004年3月至2009年9月在中国医学科学院肿瘤医院接受治疗的48例直肠神经内分泌肿瘤患者的病历。提取并分析临床病理数据,通过电话或随访信对患者进行随访以确定其生存状态。48例患者均有随访数据。进行单因素和多因素Cox回归分析以确定与总生存显著相关的预后因素。

结果

肿瘤多发生于直肠中下段,患者最突出的症状为便血和腹泻。肿瘤距肛缘的中位距离为5.0±2.257cm,肿瘤的中位直径为0.8±1.413cm。主要病理类型为典型类癌肿瘤,占患者的93.8%(45/48)。肿瘤-淋巴结-转移(TNM)分期I、II、III和IV期肿瘤分别占患者的78.8%、3.9%、9.6%和7.7%。72.9%(35/48)的患者主要治疗方法为经肛门扩大切除术。全组患者的1年、3年和5年生存率分别为100%、93.7%和91.3%。单因素分析显示年龄(P = 0.032)、肿瘤直径(P < 0.001)、组织学类型(P < 0.001)、TNM分期(P < 0.001)和手术方式(P = 0.002)均为预后因素。多因素分析显示,仅病理类型为独立预后因素(HR = 2.797,95%CI:1.676 - 4.668,P = 0.004)。

结论

直肠神经内分泌肿瘤患者中,TNM分期I期最为常见,很少见淋巴结或远处转移。肿瘤的病理类型是独立的预后因素。